(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 6.77% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.84%.
Adapthealth's revenue in 2026 is $3,286,774,000.On average, 10 Wall Street analysts forecast AHCO's revenue for 2026 to be $483,944,618,664, with the lowest AHCO revenue forecast at $459,863,033,760, and the highest AHCO revenue forecast at $500,407,171,056. On average, 10 Wall Street analysts forecast AHCO's revenue for 2027 to be $515,237,073,624, with the lowest AHCO revenue forecast at $482,992,239,600, and the highest AHCO revenue forecast at $540,271,037,592.
In 2028, AHCO is forecast to generate $543,536,337,240 in revenue, with the lowest revenue forecast at $496,189,492,344 and the highest revenue forecast at $572,787,979,920.